Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Matthew Costa and Dr David Metcalfe have both been awarded Hunterian Professorships for 2020 by the Royal College of Surgeons of England

Matt Costa and David Metcalfe

Named after the pioneering surgeon and scientist John Hunter and dating back over two centuries, the Hunterian Professorship is among the most highly-regarded annual awards in the field of surgery.

Matthew Costa, Professor of Orthopaedic Trauma Surgery has been awarded the Hunterian Professorship for his work on clinical trials and health economics.

Matt joined the University of Oxford in 2015 from the University of Warwick. His research interest is in clinical and cost effectiveness of musculoskeletal interventions and he is Chief Investigator for a series of randomised trials and associated studies. Cited widely, his work informs many guidelines from the National Institute for Health and Care Excellence (NICE).

Matt will deliver his Hunterian lecture entitled 'Changing Clinical Practice: latest evidence for clinical and cost-effectiveness in Trauma and Orthopaedic Surgery' at the British Orthopaedic Association (BOA) Congress in September.

David Metcalfe, Clinical Lecturer in Emergency Medicine, was also awarded a 2020 Hunterian Professorship for his work using routinely collected health data.

David was formerly a Fulbright Scholar at Harvard's Center for Surgery and Public Health and an Oxford-UCB Prize Fellow at the University of Oxford. His research interests lie in national clinical audit, health policy evaluation, evidence synthesis, and clinical risk prediction.

David's Hunterian lecture ('Improving hip fracture outcomes using routinely collected health data') builds on his DPhil, which was awarded the AOUK&I Trauma Research Prize and the Syme Medal of the Royal College of Surgeons of Edinburgh last year. His lecture will also be delivered at the BOA Congress in September.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.